https://www.selleckchem.com/products/VX-770.html
With the initially defined thresholds, the most widely used serum biomarkers for staging liver fibrosis (ie, APRI and FIB-4 scores) proved to be ineffective among patients with chronic hepatitis B virus infection (CH. Whether optimizing the FIB-4 and APRI thresholds could improve their diagnostic accuracy requires further research. Using data of treat-naïve CHB patients from three tertiary hospitals, we explored the optimal FIB-4 and APRI thresholds to rule in liver fibrosis accurately. Subsequently, we validated the applicability of t
Like
Comment
Share
